Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: A retrospective study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

491

HTML

3415

Figures (1-1)

464

Tables (1-1)

425

Sum=4795

Feb 14, 2009 (publication date) through Nov 11, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 14, 2009; 15(6): 713-716
Published online Feb 14, 2009. doi: 10.3748/wjg.15.713

Table 1 Adverse effects in this series of 24 patients with HCC in non-cirrhotic liver treated by chemotherapy (ECC regimen)

Adverse effets	Grade 1-2	Grade 3-4 (%)
Alopecia	8	-
Neutropenia	4	4 (17)
Mucositis	4	0
Diarrhea	2	0
Renal failure	1	0
Asthenia	2	0
Hand-foot syndrome	5	0
Nausea, vomiting	12	2 (4)
Anemia	2	0
Coronary spasm	0	1
Percentages not given in this column

One patient died suddenly during the first course of chemotherapy.

Citation: Edeline J, Raoul JL, Vauleon E, Guillygomac’h A, Boudjema K, Boucher E. Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: A retrospective study. World J Gastroenterol 2009; 15(6): 713-716
URL: https://www.wjgnet.com/1007-9327/full/v15/i6/713.htm
DOI: https://dx.doi.org/10.3748/wjg.15.713